Urine Tests for Cancer Detection in Children
No single urine test can reliably rule out cancer in children, and routine urinalysis is not recommended as a cancer screening tool in asymptomatic pediatric patients. However, specific urine tests may be indicated based on clinical presentation, symptoms, or known cancer predisposition syndromes.
Context-Specific Urine Testing Recommendations
For Children with Suspected Urinary Tract Malignancies
Urinalysis for hematuria is the primary urine-based screening test when bladder cancer is suspected, though it has significant limitations:
- Microscopic hematuria (≥5 red blood cells per high power field) warrants further evaluation with imaging (renal and bladder ultrasound) rather than relying on urine tests alone to exclude malignancy 1
- Annual urinalysis for hematuria is recommended beginning at age 10 years specifically for children with Costello syndrome due to elevated bladder cancer risk 1
- Urine cytology has poor sensitivity, particularly for low-grade tumors, making it unreliable for ruling out bladder cancer 2
For Children with Known Cancer or Cancer Predisposition
Urinalysis and urine culture serve different purposes in pediatric oncology patients:
- In children with fever and neutropenia during cancer treatment, obtain urinalysis and urine culture before starting antibiotics when a clean-catch specimen can be collected without delaying treatment 1
- Pyuria is present in only 4% of urinary tract infections during neutropenia (compared to 68% in non-neutropenic patients), so absence of pyuria does not rule out infection 1
- For cancer survivors previously treated with ifosfamide or total body irradiation, annual urinalysis screening (checking for proteinuria ≥1+, glucosuria, or ≥5 RBCs/HPF) detects late genitourinary complications, with abnormal findings in 5.3% of screenings 3
Specific Biomarker Testing Limitations
Avoid urinary VMA/HVA testing for neuroblastoma screening in children with Costello syndrome due to high false-positive rates 1
Critical Pitfalls to Avoid
- Do not rely on nitrite testing alone to exclude urinary tract pathology in children, as it has only 53% sensitivity despite 98% specificity 4, 5
- Do not use urinalysis as a standalone cancer screening tool in asymptomatic children without specific risk factors, as there is inadequate evidence supporting this approach 1
- Do not delay imaging (ultrasound or advanced imaging) when clinical suspicion for malignancy exists, as urine tests cannot definitively exclude cancer 6
Evidence-Based Algorithm
For a child with concerning symptoms (hematuria, abdominal mass, unexplained weight loss):
- Obtain urinalysis to document hematuria and assess for infection 1, 5
- Proceed immediately to imaging (renal and bladder ultrasound) rather than waiting for additional urine test results 6
- Add urine culture if infection is suspected, recognizing that 10-50% of culture-proven UTIs have false-negative urinalysis 5
- Consider specialized testing only in specific genetic syndromes (annual urinalysis for hematuria in Costello syndrome patients ≥10 years) 1
The strength of evidence for using urine tests to rule out cancer in children is weak, with most guidelines emphasizing that clinical evaluation and imaging are superior to urine-based screening for cancer detection 1, 2.